Advertisement

Advances in Paediatric Renal Replacement Therapy

  • Malcolm G. Coulthard
Chapter

Abstract

Most children who require acute renal replacement therapy (RRT) do not have primary renal diseases, but are managed in paediatric intensive care units (PICUs) for renal impairment that has occurred as a consequence of being critically ill. The primary driver of their acute renal failure (ARF) is usually kidney under-perfusion due to hypotension, which may be caused by intravascular hypovolaemia, or cardiac failure, or vasodilatation associated with sepsis, or combinations of these. Many authors prefer the term acute kidney injury (AKI) to ARF as it emphasises the fact that some children acquire long-term renal damage, but this is not logical because in many cases the kidney dysfunction results from reversible, protective physiological renal responses which do not result in any tissue injury, though acute proximal tubular necrosis (ATN) and more extensive cortical necrosis are frequently seen. The two commonest paediatric indications for RRT today are recent open-heart surgery associated with fluid overload, and multiple-organ dysfunction syndrome (MODS) [1–5]. Sometimes, RRT is used to augment normal kidney function to rapidly remove toxic metabolites, such as ammonia in babies born with rare genetic metabolic conditions [6].

References

  1. 1.
    Pichler G, Rödl S, Mache C, Trop M, Ring E, Zobel G. Two decades’ experience of renal replacement therapy in paediatric patients with acute renal failure. Eur J Pediatr. 2007;166(2):139–44.CrossRefGoogle Scholar
  2. 2.
    Selewski DT, Charlton JR, Jetton JG, Guillet R, Mhanna MJ, Askenazi D, et al. Neonatal acute kidney injury. Pediatrics. 2015;136:e463–73.CrossRefGoogle Scholar
  3. 3.
    Jhang WK, Kim YA, Ha EJ, Lee YJ, Lee JH, Park YS, et al. Extrarenal sequential organ failure assessment score as an outcome predictor of critically ill children on continuous renal replacement therapy. Pediatr Nephrol. 2014;29:1089–95.CrossRefGoogle Scholar
  4. 4.
    Sutherland SM, Alexander SR. Continuous renal replacement therapy in children. Pediatr Nephrol. 2012;27:2007–16.CrossRefGoogle Scholar
  5. 5.
    Santiago MJ, Lopez-Herce J, Urbano J, Solana MJ, del Castillo J, Ballestero Y, et al. Clinical course and mortality risk factors in critically ill children requiring continuous renal replacement therapy. Intensive Care Med. 2010;36:843–9.CrossRefGoogle Scholar
  6. 6.
    Westrope C, Morris K, Burford D, Morrison G. Continuous hemofiltration in the control of neonatal hyperammonemia: a 10-year experience. Pediatr Nephrol. 2010;25:1725–30.CrossRefGoogle Scholar
  7. 7.
    McCaffrey J, Dhakal AK, Milford DV, Webb NJA, Lennon R. Recent developments in the detection and management of kidney injury. Arch Dis Child. 2017;102(1):91–6.CrossRefGoogle Scholar
  8. 8.
    Evangelopoulos AA, Vallianou NG, Bountziouka V, Katsagoni C, Bathrellou E, Vogiatzakis ED, et al. Association between serum cystatin C, monocytes and other inflammatory markers. Intern Med J. 2011;42:517–22.CrossRefGoogle Scholar
  9. 9.
    Raina R, Chauvin AM, Bunchman T, Askenazi D, Deep A, Ensley MJ, et al. Treatment of AKI in developing and developed countries: an international survey of pediatric dialysis modalities. PLoS One. 2017;12:e0178233.CrossRefGoogle Scholar
  10. 10.
    Coulthard MG, Crosier J, Griffiths C, Smith J, Drinnan M, Whitaker M, et al. Haemodialysing babies weighing <8 kg with the Newcastle infant dialysis and ultrafiltration system (Nidus); comparison with peritoneal and conventional haemodialysis. Pediatr Nephrol. 2014;29:1869–71.CrossRefGoogle Scholar
  11. 11.
    Shaheen I, Harvey B, Watson AR. Haemofiltration therapy. Paediatr Child Health. 2008;19:121–6.CrossRefGoogle Scholar
  12. 12.
    Sohn YB, Paik KH, Cho HY, Kim SJ, Park SW, Kim ES, et al. Continuous renal replacement therapy in neonates weighing less than 3 kg. Korean J Pediatr. 2012;55:286–92.CrossRefGoogle Scholar
  13. 13.
    Liu ID, Ng K-H, Lau PY-W, Yeo WS, Koh P-L, Yap H-K. Use of HF20 membrane in critically ill unstable low-body-weight infants on inotropic support. Pediatr Nephrol. 2013;28:819–22.CrossRefGoogle Scholar
  14. 14.
    Askenazi DJ, Goldstein SL, Koralkar R, Fortenberry J, Baum M, Hackbarth RM, et al. Continuous renal replacement therapy for children ≤10 kg: a report from the prospective pediatric continuous renal replacement therapy registry. J Pediatr. 2013;162:587–92.CrossRefGoogle Scholar
  15. 15.
    Ronco R, Garzotto F, Brendolan A, Zanella M, Bellettato M, Vedovato S, et al. Continuous renal replacement therapy in neonates and small infants: development and first-in-human use of a miniaturised machine (CARPEDIEM). Lancet. 2014;383:1807–13.CrossRefGoogle Scholar
  16. 16.
    Askenazi D, Ingram D, White S, Cramer M, Borasino S, Coghill C, et al. Smaller circuits for smaller patients: improving renal support therapy with Aquadex. Pediatr Nephrol. 2016;31:853–60.CrossRefGoogle Scholar
  17. 17.
    Symons JM, Brophy PD, Gregory MJ, McAfee N, Somers MJG, Bunchman TE, et al. Continuous renal replacement therapy in children up to 10 kg. Am J Kid Dis. 2003;41:984–9.CrossRefGoogle Scholar
  18. 18.
    FDA Updated public health notification: Gambro Prisma® continuous renal replacement system. 2006. http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm062100.htm.
  19. 19.
    Jander A, Tkaczyk M, Pagowska-Klimek I, Pietrzykowski W, Moll J, Krajewski W, et al. Continuous veno-venous hemodiafiltration in children after cardiac surgery. Eur J Cardiothorac Surg. 2007;31:1022–8.CrossRefGoogle Scholar
  20. 20.
    Gambro Lundia AB. The Prismaflex® system. www.gambro.com/PageFiles/6046/Prismaflex-5-System-brochure.pdf.
  21. 21.
    Coulthard MG, Sharp J. Haemodialysis and ultrafiltration in babies weighing under 1000 g. Arch Dis Child Fetal Neonatal Ed. 1995;73:F162–5.CrossRefGoogle Scholar
  22. 22.
    Everdell NL, Coulthard MG, Crosier J, Keir MJ. A machine for haemodialysing very small infants. Pediatr Nephrol. 2005;20:636–43.CrossRefGoogle Scholar
  23. 23.
    Coulthard MG. Ultra-small neonatal dialysis circuits do not maintain safe fluid balance. Pediatr Nephrol. 2016;31:1033.CrossRefGoogle Scholar
  24. 24.
    Nishimi S, Ishikawa K, Oda S, Furukawa H, Takada A, Chida S. In vitro ability of a novel system for neonatal extracorporeal renal replacement therapy with ultra-small volume circuit for removing solutes. J Iwate Med Assoc. 2015;67:215–23.Google Scholar
  25. 25.
    Nishimi S, Ishikawa K, Sasaki M, Furukawa H, Takada A, Chida S. Ability of a novel system for neonatal extracorporeal renal replacement therapy with an ultra-small volume circuit to remove solutes in vitro. Pediatr Nephrol. 2016;31:493–500.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Malcolm G. Coulthard
    • 1
  1. 1.Great North Children’s HospitalNewcastle-upon-TyneUK

Personalised recommendations